RQB Ravenquest Biomed Inc

RavenQuest Lists Warrants

RavenQuest Lists Warrants

VANCOUVER, British Columbia, June 29, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) (OTCQB:RVVQF) (Frankfurt:1IT) (RavenQuest”) is pleased to announce that warrants issued pursuant to its February 28, 2018 brokered private placement (the “Warrants”) have been approved for listing by the Canadian Securities Exchange (the “CSE”). Each Warrant is exercisable for a two-year period from the date of issuance at a price of $1.50 per common share, subject to acceleration in the event that the closing price of the Company’s common shares on the CSE is greater than $2.75 for a period of ten consecutive trading days. The Warrants will commence trading on the CSE at the open of markets on July 3, 2018 under the ticker symbol RQB.WT.

About RavenQuest BioMed Inc.

RavenQuest is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.  RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta.  RavenQuest maintains a research partnership with Montreal's McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant.

The Company focuses on partnerships with Indigenous communities and has announced an MOU to construct a cannabis production facility on sovereign land of Fort McMurray First Nation #468.  RavenQuest has also recently announced an LOI to acquire Western Agripharma Ltd., a late stage application with a production facility under construction on British Columbia's sunshine coast, a short ferry ride from Vancouver, BC.

On Behalf of the Board of Directors of

RAVENQUEST BIOMED INC.

"George Robinson"

Chief Executive Officer

   
For further information, please contact: Mathieu McDonald, Corporate Communications
  604-484-1230
   

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

EN
29/06/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ravenquest Biomed Inc

 PRESS RELEASE

RavenQuest Provides Corporate Update

Vancouver, British Columbia--(Newsfile Corp. - January 28, 2020) - RavenQuest BioMed Inc. (CSE: RQB) (OTCQB: RVVQF) (FSE: 1IT) (the "Company" or "RavenQuest"), is pleased to provide the following update on all aspects of the Company's business plans for 2020 and beyond.RavenQuest has spent the last few months extensively reviewing the cannabis industry in Canada and internationally. The following are our key objectives near term:The Company's focus will be a technology company that grows cannabis using our technologies. This means we will be focusing on and growing our Consulting and Technolo...

 PRESS RELEASE

RavenQuest BioMed Names New Legal Counsel and Auditors

RavenQuest BioMed Names New Legal Counsel and Auditors VANCOUVER, British Columbia, Dec. 23, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), today announced that, as part of the ongoing evolution of its corporate strategy, it has retained Farris LLP as its legal counsel and Dale Matheson Carr-Hilton Labonte LLP as its auditors. RavenQuest CEO, George Robinson, stated, “from a cannabis perspective, both Farris LLP and Dale Matheson Carr-Hilton Labonte LLP bring the experience, perspective and expertise we are looking ...

 PRESS RELEASE

RavenQuest Files Response to Statement of Claim and Counter Claim

RavenQuest Files Response to Statement of Claim and Counter Claim VANCOUVER, British Columbia, Dec. 18, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”).  On November 6, 2019 the Company announced that it and others have been sued in the Federal Court of Canada for alleged patent infringement of a stackable modular orbital gardening patent recently issued to Roto-Gro Inc. (). Today the Company announced that it has served Roto-Gro Inc. with its Statement of Defence and Counterclaim and that the pleading has been filed ...

 PRESS RELEASE

RavenQuest Announces Change to Board of Directors

RavenQuest Announces Change to Board of Directors VANCOUVER, British Columbia, Nov. 29, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), today announced that Cassidy McCord has been appointed director of the Company. Ms. McCord’s bio can be found below.  RavenQuest further announces the resignation from the board of Mark Ahrens-Townsend. “As RavenQuest evolves toward profitability, the composition of our board has taken shape to reflect our plans for 2020 and beyond," said George Robinson, RavenQuest CEO. "To fully re...

 PRESS RELEASE

RavenQuest Announces Changes to Board of Directors

RavenQuest Announces Changes to Board of Directors VANCOUVER, British Columbia, Nov. 27, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), today announced that Usama Chaudhry and Jatinder Dhaliwal have been appointed directors of the Company.  Mr. Chaudhry has also been appointed as interim CFO for the Company.  Full bios for each gentleman can be found below.  RavenQuest further announces the resignations from the board of Anton Drescher, Hendrik van Alphen and David Cross, CFO. “As our Company continues to evolve, we...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch